Hervor Therapeutics
Clinical trials sponsored by Hervor Therapeutics, explained in plain language.
-
Experimental cancer cell therapy trial stopped early after single patient
Disease control TerminatedThis early-phase trial tested a new treatment called HV-101 for people with advanced solid tumors that had come back or spread. The treatment uses a patient's own immune cells (TILs) taken from their tumor, grown in a lab, and then given back to fight the cancer. The study was st…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
Personalized cell therapy takes on advanced cancers
Disease control TerminatedThis study tested a treatment called TIL therapy for people with advanced solid tumors. Doctors take immune cells from a patient's tumor, grow them in a lab, and put them back into the patient to attack the cancer. The goal was to check safety and see if tumors shrink. The study …
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:54 UTC